SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G - Statement of acquisition of beneficial ownership by individuals:
SEC Accession No. 0001104659-14-010552
Filing Date
2014-02-14
Accepted
2014-02-14 15:52:49
Documents
1
Group Members
ALTA BIOPHARMA MANAGEMENT III, LLCALTA BIOPHARMA PARTNERS III GMBH & CO. BETEILIGUNGS KGALTA EMBARCADERO BIOPHARMA PARTNERS III, LLCEDWARD HURWITZEDWARD PENHOETFARAH CHAMPSI

Document Format Files

Seq Description Document Type Size
1 SC 13G a14-5728_5sc13g.htm SC 13G 253848
  Complete submission text file 0001104659-14-010552.txt   255775
Mailing Address 3876 BAY CENTER PLACE HAYWARD CA 94545
Business Address 3876 BAY CENTER PLACE HAYWARD CA 94545 510-293-8800
CymaBay Therapeutics, Inc. (Subject) CIK: 0001042074 (see all company filings)

IRS No.: 943103561 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G | Act: 34 | File No.: 005-87950 | Film No.: 14616060
SIC: 2834 Pharmaceutical Preparations

Mailing Address ONE EMBARCADERO CENTER, SUITE 3700 SAN FRANCISCO CA 94111
Business Address ONE EMBARCADERO CENTER, SUITE 3700 SAN FRANCISCO CA 94111 4153624022
ALTA BIOPHARMA PARTNERS III LP (Filed by) CIK: 0001257444 (see all company filings)

IRS No.: 050573803 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G